The estimated Net Worth of John E Celentano is at least $301 Thousand dollars as of 31 May 2019. Mr. Celentano owns over 20,000 units of Teligent Inc stock worth over $3,400 and over the last 16 years he sold TLGT stock worth over $261,811. In addition, he makes $36,053 as Chairman of the Board at Teligent Inc.
Sign up
Mr. Celentano TLGT stock SEC Form 4 insiders trading
John has made over 11 trades of the Teligent Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of TLGT stock worth $13,000 on 31 May 2019.
The largest trade he's ever made was exercising 221,580 units of Teligent Inc stock on 10 September 2010 worth over $5,211,562. On average, John trades about 17,673 units every 117 days since 2008. As of 31 May 2019 he still owns at least 20,000 units of Teligent Inc stock.
You can see the complete history of Mr. Celentano stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Celentano biography
John E. Celentano serves as Chairman of the Board of the Company. Previously, Mr. Celentano held key senior leadership positions with Bristol-Myers Squibb Company including: President, Bristol-Myers Squibb Healthcare Group (Mead Johnson Nutrition, ConvaTec, and Medical Imaging); Regional President roles in Emerging Markets/Asia Pacific, Latin America/Canada, and UK/Northern Europe; Senior Vice President of Human Resources, Public Affairs and Philanthropy; and Senior Vice President of Strategy and Productivity. While at Bristol-Myers, Mr. Celentano was an active participant in the development of their biopharma strategy and led major initiatives on productivity transformation, streamlining operations to support the company's growth opportunities. Mr. Celentano currently works as an independent senior advisor and serves on the Board of privately held YourEncore Inc. He holds a B.A. from the University of Delaware and an MBA from Drexel University.
What is the salary of John Celentano?
As the Chairman of the Board of Teligent Inc, the total compensation of John Celentano at Teligent Inc is $36,053. There are no executives at Teligent Inc getting paid more.
How old is John Celentano?
John Celentano is 60, he's been the Chairman of the Board of Teligent Inc since 2020. There are 5 older and 1 younger executives at Teligent Inc. The oldest executive at Teligent Inc is Steven Koehler, 69, who is the Independent Director.
What's John Celentano's mailing address?
John's mailing address filed with the SEC is C/O TELIGENT, INC., 105 LINCOLN AVENUE, BUENA, NJ, 08310.
Insiders trading at Teligent Inc
Over the last 9 years, insiders at Teligent Inc have traded over $1,419,503 worth of Teligent Inc stock and bought 245,910 units worth $400,963 . The most active insiders traders include James C Gale, Sciences Opportunities Fund..., and John E Celentano. On average, Teligent Inc executives and independent directors trade stock every 89 days with the average trade being worth of $8,816. The most recent stock trade was executed by Philip K Yachmetz on 16 July 2021, trading 7,835 units of TLGT stock currently worth $1,332.
What does Teligent Inc do?
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market.
What does Teligent Inc's logo look like?
Complete history of Mr. Celentano stock trades at Teligent Inc and Bristol-Myers Squibb Co
Teligent Inc executives and stock owners
Teligent Inc executives and other stock owners filed with the SEC include:
-
John Celentano,
Chairman of the Board -
Steven Koehler,
Independent Director -
Bhaskar Chaudhuri,
Independent Director -
Carole Ben-Maimon,
Independent Director -
Thomas Sabatino,
Independent Director -
Philip Yachmetz,
Chief Legal Officer, Corporate Secretary -
Timothy Sawyer,
President, Chief Executive Officer, Director -
Martin Wilson,
General Counsel -
Stephen Richardson,
Chief Scientific Officer -
Jenniffer Collins,
CFO -
Narendra N Borkar,
Director -
Sciences Opportunities Fund...,
-
James C Gale,
Director -
Jason Grenfell Gardner,
President & CEO -
Damian Finio,
CFO -
Paolantonio Ernest Robert De,
Chief Financial Officer -
William S Marth,
Director -
R Carter Pate,
Director